Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Sep 30;12:987965. doi: 10.3389/fonc.2022.987965

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Wang, Song, Geng, Gao, Xu, Tang, Ni, Chen, Chen, Wang, Fu, Feng, Yu, Wang and Yang

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Treatment response and hematological recovery in the training cohort after CAR-T therapy. Treatment response (A) and hematological recovery (B) in patients with B-ALL and LBCL. Compared to patients with B-ALL, lower CR rate while higher BR rate were observed in patients with LBCL. (C) Incidences of severe neutropenia, anemia, and thrombocytopenia in Non-BR patients. CAR-T, chimeric antigen receptor T cell; B-ALL, B-cell acute lymphoblastic leukemia; LBCL, large B-cell lymphoma; CR, complete response; BR, blood complete recovery; Non-BR, non-blood complete recovery.